Home | Articles
Published on:May 2023
Indian Journal of Pharmaceutical Education and Research, 2023; 57(2s):s213-s225.
Review Article | doi:10.5530/ijper.57.2s.25

Prevalence and Complications of Diabetes Mellitus in India: A Systematic Review


Authors and affiliation (s):

Swathy Govindaswamy1,*, Ponnaian Sundaram Dhivya2, Sridevi Sangeetha Kothandaraman Sivaprakasam3

1Department of Pharmacy Practice, KMCH College of Pharmacy, Coimbatore, Tamil Nadu, INDIA.

2Department of Biomedical Science, Bharathidasan University, Tiruchirapalli, Tamil Nadu, INDIA.

3Department of Pharmacology, Faculty of Allied Health Sciences, Dr. MGR Educational and Research Institute, Chennai, Tamil Nadu, INDIA.

Abstract:

Background and Aim: Diabetes is progressively becoming a vital chronic disease burden worldwide, mainly in developing countries such as India, necessitating a shift in healthcare priorities and advanced data on the epidemiology and impact of diabetes to help plan and prioritize health programs. We systematically reviewed the literature on diabetes prevalence and its complications in India. Methodology: This systematic review focuses on diabetes prevalence and complications in India from January 2000 to September 2021. Literature searches were conducted using electronic databases. Results: Diabetes prevalence ranged from 2.02% in rural Madhya Pradesh to 40.3% in Tamil Nadu. Diabetes prevalence was significantly higher in urban areas than in rural areas. The prevalence of prediabetes varied across Indian states ranging from 2.4% in Meghalaya to 47.6% in Delhi. The prevalence of chronic diabetes complications ranged from 4.8% to 21.7% for retinopathy, 0.9% to 62.3% for nephropathy, and 10.5% to 44.9% for neuropathy. Conclusion: Diabetes is a significant and widespread health problem in India. Dissimilarity in the prevalence of diabetes between individual states is observed. Most diabetes patients experience chronic complications of diabetes. Consequently, it is essential to map the urgent preventive approach to reduce the further increase in areas with high prevalence.

Keywords: Type 2 diabetes, Diabetes complications, India, Urban, Rural.

 




 

Impact Factor

IJPER - An Official Publication of Association of Pharmaceutical Teachers of India is pleased to announce continued growth in the Latest Release of Journal Citation Reports (source: Web of Science Data).

 

Impact Factor® as reported in the 2023 Journal Citation Reports® (Clarivate Analytics, 2023): 0.8

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmaceutical Education and Research (IJPER) [ISSN-0019-5464] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 1967.

DOI HISTORY

IJPER uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2013 are being assigned DOIs for its permanent URLs